A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Clinical trial NCT05678205 · WITHDRAWN

Trial details

NCT number: NCT05678205
Sponsor: Artiva Biotherapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Gastric Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2023-08-01
Primary completion: 2027-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.